Abstract: Platinosis (severe dermatitis and/or asthma) may be broadly defined as the effects of soluble platinum salts on people exposed to them occupationally. Platinum coordination complexes are widely used in the treatment of a variety of solid tumors. However, the clinical use of cisplatin (the most useful agent) is limited by the development of nephrotoxicity. High dose exposure of soluble platinum could possibly induce nephrotoxicity, occupationally. Urinary citrate is freely filtered at the glomerulus, and its reabsorption in the proximal tubule is the major determinant of rate. In this study, we exposed isolated rat renal brush border membrane vesicles (BBMV) to cisplatin and examined their citrate uptake characteristics. BBMV were prepared by the divalent cation precipitation method. Citrate uptake was measured by the Millipore rapid membrane filtration technique. The preincubation of BBMV with 5 mM of cisplatin for 4 and 8 hours significantly inhibited citrate uptake compared with that of the control BBMV. These findings might contribute to nephrotoxicity in cisplatin therapy.
Platinosis is a disease caused, not by metallic platinum, but usually by its complex salts, mainly chloroplatoinates. The cutaneous and respiratory allergic manifestations elicited by these salts mainly affect workmen in platinum refining workshops 1) . Hunter et al. 2) described rhinorrhea in 52 of 91 exposed workers employed in four platinum refinerys. Platinum coordination complexes (PtCx) are potent against several types of cancer but are often nephrotoxic 3) . Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most useful chemotherapeutic agents, but its clinical use is limited by its acute nephrotoxic potential. CDDP nephrotoxicity is characterized by early impairment of water and solute tubular transport processes, leading to marked increases in urinary excretion of sodium, magnesium, and glucose. CDDP inhibits the activity of several proteins with SH groups essential for the activity of glucose transporters of the rabbit renal brush border membrane 4) . However, the underlying mechanisms have not been explored 5) . High dose accidental exposure of soluble platinum in platinum refinery and pharmaceutical factory could possibly induce nephrotoxicity, occupationally.
Renal citrate excretion is important with regard to both the prevention of kidney stones and the acid-base balance. Citrate is freely filtered at the glomerulus, and its reabsorption by the transporters in the proximal tubule is the major determinant of rate 6) . In the present study, we exposed rat renal brush border membrane vesicles (BBMV) to CDDP and investigated the direct effect of CDDP exposure on the K SATO et al.
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14 C-citrate (spec. act. 50 mCi/m mol) was obtained from the New England Nuclear Corp. (Boston, MA). All other chemicals were reagent grade and purchased from commercial sources.
The animals used for these experiments were SPF male Wistar rats (CLEA, Japan, Inc.) weighing 339-442 g (n=6). They were maintained in a temperature-and photoperiodcontrolled animal house with ad libitum access to a standard diet and tap water.
Each membrane specimen was prepared from the cortex of both kidneys of a single rat by a modification of the MgCl 2 -precipitation technique 7) and used within 10 h after preparation. During preparation, all materials were maintained on ice or at 4°C. Briefly, the rats were anesthetized with an injection of chloral hydrate (360 mg/ kg body wt) intraperitoneally. The renal cortices were removed and placed in an isolation buffer consisting of 50 mM of Mannitol and 2 mM of Tris-(hydroxymethyl)-aminomethane (Tris)/HCl (pH 7.0). They were homogenized in a glass Teflon homogenizer (Iuchi Co., Ltd., Japan) and a polytron homogenizer. A concentration of MgCl 2 (1M) was added to the resultant homogenate to give a final concentration of 10 mM. This mixture was stirred for 20 min in a cold room and then centrifuged for 15 min at 3,000 g. The supernatant was collected and centrifuged for 20 min at 43,000 g. The pellet containing the BBMV was resuspended in isolation buffer and centrifuged for 15 min at 3,000 g. The supernatant was collected and centrifuged at 43,000 g. The final pellet containing the purified BBMV was resuspended in 260 mM of mannitol and 20 mM of N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)/Tris (pH 7.0).
The purity of membrane preparations was assessed from the enrichment of alkaline phosphatase (Alp) 8) and leucine aminopeptitase (LAP) 9) in the final preparation as compared with that of the original homogenate.
Protein determination was conducted by the method of Lowry et al. 10) with crystalline bovine serum albumin as the standard.
Transport measurements were performed in freshly isolated BBMV by the Millipore rapid membrane filtration technique 11, 12) . For the experiment in which BBMV were preincubated with cisplatin, membrane vesicles (10 µl) were preincubated at 30°C with 20 µl of preincubation solution consisting of 260 mM of mannitol and 20 mM of HEPES/ Tris (pH 7.0) with or without 5 mM of cisplatin for an appropriate interval. Citrate uptake was initiated by the addition of 40 µl of uptake solution consisting of 100 µM of 14 C-citrate, 130 mM of NaCl and 20 mM of HEPES/Tris (pH 7.0). After thirty seconds, the uptake was terminated by the addition of 4 ml of ice-cold solution consisting of 130 mM of NaCl and 20 mM of HEPES/Tris (pH 7.0). The solution was then rapidly filtered through a Millipore filter (DAWP02500: pore size 0.65 µm) and washed twice with 4 ml of ice-cold stop solution under vacuum suction. The background uptake was similarly determined by adding 4 ml of ice-cold stop solution to membrane vesicles (10 µl) before adding 40 µl of uptake solution at 4°C. The nonspecific binding was always <0.5% of the total count in the uptake solution. The radioactivity associated with the filters was measured with a liquid scintillation counter (LSC-3500, Aloka). All uptake measurements were performed at 30°C in triplicate, and the uptake was calculated on the basis of the specific activity measured in each experiment. The nonspecific binding value was subtracted from the experimental value. The vesicular uptake was expressed as picomoles 14 C-citrate per mg of protein and presented as mean ± S.E. Student's t-test was used to analyze the differences among the groups. Significance was accepted at P<0.05.
The purity of the BBMV preparations was assayed by determining the BBM-specific marker enzymes Alp and LAP. The specific activities of the two enzymes in the BBM fraction were enriched to a 10-fold higher level than those in the original homogenate.
Four and 8 h preincubation with 5 mM CDDP significantly inhibited the citrate uptake compared to that without CDDP (P<0.05). Four h preincubation induced about 40% reduction of that of control. Eight h preincubation induced about 70% reduction (Fig. 1) . These findings indicate that CDDP preincubation resulted in a time-dependent inhibition of citrate uptake by BBMV.
Although the toxic mechanism of cisplatin might be different from those of cadmium and mercury, we previously reported the preincubation of rat BBMV with cadmium 13) and mercury 14) . Preincubation of BBMV with 2 and 10 mM CdCl 2 for 1 min significantly inhibited citrate uptake compared with that of BBMV without Cd. Analysis of the time course of citrate uptake during 30-min preincubation of BBMV with 0.5 mM Cd also revealed a significant reduction in the uptake compared with that of the control BBMV 13) . In addition, preincubation of BBMV with 0.5 and 2 mM of Hg for 1 min significantly inhibited citrate uptake compared with that of BBMV without Hg preincubation. The analysis of the time course of citrate uptake during 10 and 30 min preincubation of BBMV with 0.1 mM of Hg also revealed a significant reduction in the uptake compared with that of the control BBMV without preincubation 14) . In this study, the preincubation of BBMV with 5 mM cisplatin for 4 and 8 hours significantly inhibited citrate uptake compared with that of the control BBMV without preincubation. These findings might contribute to nephrotoxicity in cisplatin therapy. In cadmium-intoxicated rats, the percentages equilibrium values were also significantly inhibited 15) . Therefore, in vivo experiments in cisplatin-intoxicated rats are necessary to confirm this in vitro experiment, and in vitro experiments of another platinum coordination complex (for example, carboplatin, CBDCA) are needed to further clarify the mechanism of renal disturbance in platinum coordination complex therapy. : preincubation with 0 mM of cisplatin (control),
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